| Name | Title | Contact Details |
|---|
Soda Health is a healthcare technology company focused on building solutions which eliminate health inequities and create a healthier America. Social Determinants of Health (SDOH) have a major impact on health and wellbeing, as well as the cost of care. Our mission is so important, we found a way to work SDOH into our company name.
MSU Health Care is the multi-specialty medical practice of Michigan State University, with approximately 300 physicians, nurse practitioners and physician assistants. Our providers are university researchers and academic professors, spanning 25 adult and pediatric specialties. Our commitment to education allows our providers to teach future medical professionals and participate in research. Our large clinical practice connects you to the latest medical advancements, including opportunities to participate in clinical trials. Our providers practice at office locations throughout the greater Lansing area and serve patients from Mid-Michigan, and beyond. The largest clinical practice location is the MSU Clinical Center, situated on the MSU campus in East Lansing. Our locations offer multiple primary and specialty services, as well as a pharmacy, laboratory and radiology services. Our providers also treat patients at McLaren Greater Lansing and Sparrow Hospitals, in addition to several outlying community hospitals, nursing homes, rehabilitation centers, wound care centers, and Ingham County Health Department clinics.
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.
Lifespark is a complete senior health company that helps people stay healthy at home, navigate their health options with confidence, and live fuller, more independent lives.
Bowie Memorial Hospital is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Bowie, TX. To find more information about Bowie Memorial Hospital, please visit www.bowiememorial.com